SMS Pharmaceuticals' Q1 FY 2026-27 Quarterly Results

Result Summary

• SMS Pharmaceuticals Ltd reported a 13.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 6.1%.
• Its expenses for the quarter were down by 15.0% QoQ and up 5.4% YoY.
• The net profit decreased 36.1% QoQ and increased 2.0% YoY.
• The earnings per share (EPS) of SMS Pharmaceuticals Ltd stood at 2.23 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

SMS Pharmaceuticals Ltd is a leading pharmaceutical company primarily engaged in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs). With a focus on producing quality products, the company operates within the pharmaceutical industry, catering to both domestic and international markets. While specific recent developments concerning the company are not provided, it is known for its significant role in the pharmaceutical supply chain, contributing to the production of various medicinal compounds.

Revenue

In the first quarter of Fiscal Year 2027 (Q1FY27), SMS Pharmaceuticals Ltd reported a total income of ₹208.71 crores. When compared to the previous quarter (Q4FY26), which saw a total income of ₹240.52 crores, there is a quarter-over-quarter (QoQ) decrease of 13.2%. However, when compared year-over-year (YoY) with Q1FY26, where total income was ₹196.64 crores, there is a growth of 6.1%. This indicates a positive trend on a yearly basis despite the quarterly decline.

Profitability

The company's profit before tax (PBT) for Q1FY27 was ₹27.20 crores. This represents a slight QoQ increase of 0.5% from Q4FY26, which recorded a PBT of ₹27.07 crores, and an 11.6% YoY increase from Q1FY26's PBT of ₹24.37 crores. The tax expense for Q1FY27 was ₹7.00 crores, marking a 14.8% QoQ increase and a 23.9% YoY increase. Consequently, the profit after tax (PAT) for Q1FY27 was ₹20.91 crores, showing a significant QoQ decrease of 36.1% from Q4FY26's ₹32.71 crores but a 2.0% YoY growth from Q1FY26's PAT of ₹20.49 crores.

Operating Metrics

For Q1FY27, the company's total expenses amounted to ₹181.50 crores, reflecting a 15.0% decrease from Q4FY26's ₹213.46 crores and a 5.4% increase from Q1FY26's ₹172.27 crores. The earnings per share (EPS) for Q1FY27 was ₹2.23, which decreased by 37.7% from ₹3.58 in Q4FY26 and decreased by 3.5% from ₹2.31 in Q1FY26. These figures indicate a trend where expenses have decreased on a quarterly basis, while earnings per share have shown a decline both quarterly and yearly.